Literature DB >> 25997366

Targeting the Early Step of Building Block Organization in Viral Capsid Assembly.

Ayala Lampel1, Yaron Bram1, Anat Ezer1, Ronit Shaltiel-Kario1, Jamil S Saad2, Eran Bacharach3, Ehud Gazit1,4.   

Abstract

Viral assembly, similar to other self-organizing protein systems, relies upon early building blocks, which associate into the late supramolecular structures. An initial and crucial event during HIV-1 core assembly is the dimerization of the capsid protein C-terminal domain, which stabilizes the viral capsid lattice. Thus, monitoring and manipulating this stage is desirable both from mechanistic as well as clinical perspectives. Here, we developed a fluorescent-based method for the detection and visualization of these early capsid interactions. We detected strong dimeric interactions, which were influenced by mutations in the capsid protein. We utilized this assay for potential assembly inhibitors screening, which resulted in the identification of a leading compound that hinders the assembly of capsid protein in vitro. Moreover, a derivative of the compound impaired virus production and infectivity in cell cultures. These findings demonstrate that the described assay efficiently detects the very first association events in HIV-1 capsid formation and emphasize the significance of targeting early intermolecular interactions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25997366     DOI: 10.1021/acschembio.5b00347

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  7 in total

Review 1.  Quantitative computational models of molecular self-assembly in systems biology.

Authors:  Marcus Thomas; Russell Schwartz
Journal:  Phys Biol       Date:  2017-05-23       Impact factor: 2.583

2.  A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.

Authors:  Da-Wei Zhang; Rong-Hua Luo; Lei Xu; Liu-Meng Yang; Xiao-Shuang Xu; Gregory J Bedwell; Alan N Engelman; Yong-Tang Zheng; Shan Chang
Journal:  Antiviral Res       Date:  2019-06-27       Impact factor: 5.970

3.  Specific Interaction of DARPin with HIV-1 CANTD Disturbs the Distribution of Gag, RNA Packaging, and Tetraspanin Remodelling in the Membrane.

Authors:  Sutpirat Moonmuang; Rawiwan Maniratanachote; Paninee Chetprayoon; Kanokporn Sornsuwan; Weeraya Thongkum; Koollawat Chupradit; Chatchai Tayapiwatana
Journal:  Viruses       Date:  2022-04-15       Impact factor: 5.818

Review 4.  HIV-1 Capsid Inhibitors as Antiretroviral Agents.

Authors:  Suzie Thenin-Houssier; Susana T Valente
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

Review 5.  Targeting the Virus Capsid as a Tool to Fight RNA Viruses.

Authors:  Lucie Hozáková; Barbora Vokatá; Tomáš Ruml; Pavel Ulbrich
Journal:  Viruses       Date:  2022-01-18       Impact factor: 5.048

6.  Selection and identification of an RNA aptamer that specifically binds the HIV-1 capsid lattice and inhibits viral replication.

Authors:  Paige R Gruenke; Rachna Aneja; Sarah Welbourn; Obiaara B Ukah; Stefan G Sarafianos; Donald H Burke; Margaret J Lange
Journal:  Nucleic Acids Res       Date:  2022-02-22       Impact factor: 19.160

7.  Identification of an Antiretroviral Small Molecule That Appears To Be a Host-Targeting Inhibitor of HIV-1 Assembly.

Authors:  Jonathan C Reed; Dennis Solas; Anatoliy Kitaygorodskyy; Beverly Freeman; Dylan T B Ressler; Daryl J Phuong; J Victor Swain; Kent Matlack; Clarence R Hurt; Vishwanath R Lingappa; Jaisri R Lingappa
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.